Aligos Therapeutics Inc (ALGS)
0.685
+0.03
(+4.58%)
USD |
NASDAQ |
May 17, 16:00
0.685
0.00 (0.00%)
Pre-Market: 20:00
Aligos Therapeutics Market Cap: 53.78M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 53.78M |
| May 16, 2024 | 51.16M |
| May 15, 2024 | 53.04M |
| May 14, 2024 | 54.01M |
| May 13, 2024 | 53.47M |
| May 10, 2024 | 57.04M |
| May 09, 2024 | 60.65M |
| May 08, 2024 | 61.18M |
| May 07, 2024 | 61.71M |
| May 06, 2024 | 63.27M |
| May 03, 2024 | 63.28M |
| May 02, 2024 | 66.08M |
| May 01, 2024 | 60.14M |
| April 30, 2024 | 59.75M |
| April 29, 2024 | 57.32M |
| April 26, 2024 | 61.59M |
| April 25, 2024 | 64.43M |
| April 24, 2024 | 65.29M |
| April 23, 2024 | 64.87M |
| April 22, 2024 | 63.09M |
| April 19, 2024 | 59.07M |
| April 18, 2024 | 62.47M |
| April 17, 2024 | 61.98M |
| April 16, 2024 | 65.77M |
| April 15, 2024 | 70.47M |
| Date | Value |
|---|---|
| April 12, 2024 | 78.76M |
| April 11, 2024 | 83.49M |
| April 10, 2024 | 81.91M |
| April 09, 2024 | 83.49M |
| April 08, 2024 | 84.27M |
| April 05, 2024 | 81.91M |
| April 04, 2024 | 76.60M |
| April 03, 2024 | 79.55M |
| April 02, 2024 | 77.03M |
| April 01, 2024 | 74.93M |
| March 28, 2024 | 74.16M |
| March 27, 2024 | 74.08M |
| March 26, 2024 | 77.18M |
| March 25, 2024 | 71.03M |
| March 22, 2024 | 74.91M |
| March 21, 2024 | 71.89M |
| March 20, 2024 | 72.11M |
| March 19, 2024 | 70.49M |
| March 18, 2024 | 69.62M |
| March 15, 2024 | 69.73M |
| March 14, 2024 | 65.81M |
| March 13, 2024 | 65.83M |
| March 12, 2024 | 65.83M |
| March 11, 2024 | 66.59M |
| March 08, 2024 | 63.57M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
25.95M
Minimum
Oct 23 2023
1.282B
Maximum
Jun 11 2021
309.51M
Average
65.62M
Median
Market Cap Benchmarks
| Mirum Pharmaceuticals Inc | 1.134B |
| CEL-SCI Corp | 68.78M |
| AIM ImmunoTech Inc | 20.11M |
| IGC Pharma Inc | 35.69M |
| NovaBay Pharmaceuticals Inc | 4.487M |
Market Cap Related Metrics
| PS Ratio | 3.968 |
| Price to Book Value | 0.8994 |
| Price | 0.685 |
| Earnings Yield | -207.9% |